MSA
CVS icon

Marino Stram & Associates’s CVS Health CVS Stock Holding History

Marino Stram & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$670K Buy
6,477
+442
+7% +$39.5K 0.11% 108
2026
Q1 		$433K Buy
6,035
+28
+0.5% +$2.16K 0.08% 127
2025
Q4 		$477K Sell
6,007
-37
-0.6% -$2.92K 0.09% 121
2025
Q3 		$456K Buy
6,044
+2
+0% +$137 0.08% 133
2025
Q2 		$417K Buy
6,042
+33
+0.5% +$2.16K 0.08% 121
2025
Q1 		$407K Sell
6,009
-141
-2% -$8.44K 0.09% 116
2024
Q4 		$276K Sell
6,150
-282
-4% -$15.8K 0.06% 140
2024
Q3 		$404K Hold
6,432
– – 0.09% 117
2024
Q2 		$380K Buy
6,432
+114
+2% +$7.13K 0.09% 115
2024
Q1 		$504K Buy
6,318
+2
+0% +$153 0.12% 111
2023
Q4 		$499K Sell
6,316
-19
-0.3% -$1.35K 0.13% 105
2023
Q3 		$442K Buy
6,335
+163
+3% +$11.5K 0.13% 108
2023
Q2 		$427K Sell
6,172
-237
-4% -$16.9K 0.12% 107
2023
Q1 		$476K Sell
6,409
-80
-1% -$6.71K 0.14% 100
2022
Q4 		$605K Sell
6,489
-100
-2% -$9.65K 0.19% 84
2022
Q3 		$628K Buy
6,589
+88
+1% +$8.71K 0.23% 72
2022
Q2 		$602K Buy
6,501
+129
+2% +$12.6K 0.21% 77
2022
Q1 		$645K Buy
6,372
+174
+3% +$18.3K 0.2% 84
2021
Q4 		$639K Buy
6,198
+323
+5% +$29.8K 0.2% 86
2021
Q3 		$499K Buy
+5,875
New +$492K 0.17% 91
2021
Q2 		– Sell
-4,743
Closed -$357K – 253
2021
Q1 		$357K Buy
4,743
+1,377
+41% +$100K 0.14% 104
2020
Q4 		$230K Buy
+3,366
New +$219K 0.1% 112
2019
Q2 		– Sell
-997
Closed -$54K – 184
2019
Q1 		$54K Sell
997
-13
-1% -$802 0.04% 149
2018
Q4 		$66K Buy
1,010
+2
+0.2% +$149 0.06% 135
2018
Q3 		$79K Buy
1,008
+11
+1% +$786 0.06% 141
2018
Q2 		$64K Buy
997
+460
+86% +$30.3K 0.06% 146
2018
Q1 		$33K Buy
537
+2
+0.4% +$143 0.03% 198
2017
Q4 		$39K Buy
+535
New +$38.9K 0.04% 190

Other funds holding CVS

Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Marino Stram & Associates's CVS Position: Q2 2026 in Review

Marino Stram & Associates increased its CVS Health (CVS) stake by 7.3% in Q2 2026, buying an estimated $39.5K and bringing the position to 6,477 shares worth $670K. The position accounts for 0.11% of the portfolio, ranked #108.

Marino Stram & Associates first reported a position in CVS in Q4 2017 and has held it in 28 quarters since. 936 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Marino Stram & Associates held 6,477 shares of CVS Health worth $670K as of Q2 2026.
  • Marino Stram & Associates bought 442 CVS Health shares in Q2 2026, an estimated $39.5K.
  • CVS Health made up 0.11% of Marino Stram & Associates's portfolio in Q2 2026, its #108 holding.
  • Marino Stram & Associates first reported a position in CVS Health in Q4 2017 and has held it in 28 quarters since.
  • 936 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Marino Stram & Associates's 13F filing for Q2 2026, filed 24 Jul 2026.